{
    "code": 0,
    "data": [
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acf8adfc-56d1-43d0-8743-04557efa2692.pdf",
            "news_date": "2026-02-02 20:29:56"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015",
            "news_body": "Receipt of award in relation to arbitration proceedings in connection with Unitop Chemicals Private Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=141c2af6-2766-414f-b41a-218106429875.pdf",
            "news_date": "2026-01-29 18:26:17"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76dff9b3-52a9-4da5-9086-da3c2b3c8f52.pdf",
            "news_date": "2026-01-23 20:07:22"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q3 FY 26 for the Earnings Conference Call held on January 19 2026.",
            "news_id": "3583c177-8afc-4c6d-987f-6f7910de9652",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdf47fd1-c97d-4b4a-9207-336c0cd9f82d.pdf",
            "news_date": "2026-01-23 19:56:08",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q3 FY 26 for the Earnings Conference Call held on January 19 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdf47fd1-c97d-4b4a-9207-336c0cd9f82d.pdf",
            "news_date": "2026-01-23 19:56:08"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call for Q3 FY 26.",
            "news_id": "bfdc8a2c-6fdb-4a56-99dc-e2634e6b70e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a511da7-4d9d-4886-8500-9663de853d0f.pdf",
            "news_date": "2026-01-19 18:37:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call for Q3 FY 26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a511da7-4d9d-4886-8500-9663de853d0f.pdf",
            "news_date": "2026-01-19 18:37:45"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Rossari Biotech Limited informed the Exchange regarding Press Release dated January 17 2026 titled \" Rossari Biotech announces Q3 FY 26 Results\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aeca808c-2c14-47a0-bebd-33409cfb8f47.pdf",
            "news_date": "2026-01-19 11:47:53"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q3 & 9M FY26- Earnings Presentation.",
            "news_id": "986bcf1e-aefc-4103-9423-96e14f002da7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=845f5929-f435-44d2-97f8-efe265495347.pdf",
            "news_date": "2026-01-18 16:01:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q3 & 9M FY26- Earnings Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=845f5929-f435-44d2-97f8-efe265495347.pdf",
            "news_date": "2026-01-18 16:01:16"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of extract of Consolidated Unaudited Financial Results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25cfbb13-4372-47e7-bed1-53c515bd26d3.pdf",
            "news_date": "2026-01-18 15:39:54"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c73e9e6f-667b-4000-abde-f69fef216247.pdf",
            "news_date": "2026-01-17 16:20:06"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation of allotment of 2000 Equity Shares under Rossari Employee Stock Option Plan- 2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b773f6e-45eb-431f-ba67-af3ce7d8ee50.pdf",
            "news_date": "2026-01-17 16:12:46"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31 2025.",
            "news_id": "fe32e51b-5f4e-4762-9d3d-d6e09b2a85d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9bf25a3-e618-4935-831b-3ad703a06e5f.pdf",
            "news_date": "2026-01-17 16:07:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9bf25a3-e618-4935-831b-3ad703a06e5f.pdf",
            "news_date": "2026-01-17 16:07:16"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 17 2026.",
            "news_body": "Outcome of Board Meeting held on January 17 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d1fa407-2220-4c77-92f0-2a87240f5bb6.pdf",
            "news_date": "2026-01-17 15:58:35"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earning Conference Call for investor and analyst on Monday January 19 2026 at 04:00 P.M. (IST).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e431eb3-d6fd-40cf-8f2d-661930ac3163.pdf",
            "news_date": "2026-01-13 18:44:00"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2026 inter alia to consider and approve to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4227b6f1-8668-4036-972e-44eb9bcf5c16.pdf",
            "news_date": "2026-01-09 23:23:56"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5563ac2c-330c-4b0d-96a3-bd240ff273b4.pdf",
            "news_date": "2026-01-05 17:10:43"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=706a9a11-f1f6-4c51-abfb-6514598e5705.pdf",
            "news_date": "2025-12-29 19:14:55"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Incorporation of Rossari (Singapore) Pte. Ltd. in Republic of Singapore wholly owned subsidiary of Rossari Biotech Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0d57f53-e070-41fe-a0a8-27900b2be86b.pdf",
            "news_date": "2025-12-18 16:21:45"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On December 18 2025.",
            "news_body": "The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a7bf0ec-628b-485c-9cbb-534ec58476b3.pdf",
            "news_date": "2025-12-18 11:45:18"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation of affirmation of Credit Rating.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97709d4a-55d8-4169-9fef-de728fa3f9a9.pdf",
            "news_date": "2025-12-03 18:59:17"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b969b380-6308-46e3-80df-07509cfe30d6.pdf",
            "news_date": "2025-11-24 21:07:13"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f6a0287-5da1-47e4-8b5f-1e737507731f.pdf",
            "news_date": "2025-11-06 18:36:03"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q2 FY 26 for the Earnings Conference Call held on October 17 2025.",
            "news_id": "d2ab4544-01f6-47fe-80bd-7b631084f5e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e817dc3-1737-4f6e-82e1-e8c573f5d0c9.pdf",
            "news_date": "2025-10-27 19:35:06",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q2 FY 26 for the Earnings Conference Call held on October 17 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e817dc3-1737-4f6e-82e1-e8c573f5d0c9.pdf",
            "news_date": "2025-10-27 19:35:06"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q2 FY 26.",
            "news_id": "12ed1bf0-9f23-4584-9955-d5fca9b66a0c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8f5a873-747c-45b1-9e12-38b79f522d3b.pdf",
            "news_date": "2025-10-17 18:52:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q2 FY 26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8f5a873-747c-45b1-9e12-38b79f522d3b.pdf",
            "news_date": "2025-10-17 18:52:16"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of extract of Consolidated Unaudited Financial Results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=757563d6-94f6-477d-873a-12bad1525aa2.pdf",
            "news_date": "2025-10-17 16:45:10"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Rossari Biotech Limited informed the Exchange regarding Press Release dated October 15 2025 titled \"Rossari Biotech announces Q2 FY 26 Results\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c477655-b51d-4ed9-a81e-9ab0a3dbdbcf.pdf",
            "news_date": "2025-10-16 16:44:36"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q2 & H1 FY26 -Earnings Presentation.",
            "news_id": "4cb99cf5-267a-424b-8f9b-8e7044581197",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26fcb99d-61d3-49d9-984b-a58a424b9bd6.pdf",
            "news_date": "2025-10-16 16:34:28",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q2 & H1 FY26 -Earnings Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26fcb99d-61d3-49d9-984b-a58a424b9bd6.pdf",
            "news_date": "2025-10-16 16:34:28"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015\r\n",
            "news_body": "Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=928d8705-4feb-4eca-ba6d-1d9324f36df8.pdf",
            "news_date": "2025-10-15 21:27:26"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan - 2019.",
            "news_body": "Intimation of grant of 35000 options under Rossari Employee Stock Option Plan - 2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adc27299-cee9-4216-a73c-7150015c6453.pdf",
            "news_date": "2025-10-15 21:22:20"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation of allotment of 14400 Equity Shares under Rossari Employee Stock Option Plan - 2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eed6112-9811-4f60-ac5a-536793fe7489.pdf",
            "news_date": "2025-10-15 21:09:36"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30 2025",
            "news_id": "e7a37118-e70f-45bd-b3f6-69b9238818e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0e722d9-8a7c-4f96-b9f0-64c180541e3e.pdf",
            "news_date": "2025-10-15 21:04:54",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0e722d9-8a7c-4f96-b9f0-64c180541e3e.pdf",
            "news_date": "2025-10-15 21:04:54"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On October 15 2025.",
            "news_body": "Outcome of Board Meeting held on October 15 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5415080-bb87-4b40-a956-1b940a0549a5.pdf",
            "news_date": "2025-10-15 20:32:05"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earning Conference Call for investor and analyst on Friday October 17 2025 at 03:30 P.M. (IST).\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b87cd702-878c-4239-8efe-913fdf0362ff.pdf",
            "news_date": "2025-10-09 19:19:31"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change In Communication Details Of Registrar And Share Transfer Agent",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding change in communication details of MUFG Intime India Private Limited (Registrar and Share Transfer Agent) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=868a9351-125a-4384-a1ce-076ed6746723.pdf",
            "news_date": "2025-10-09 19:09:16"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=519980d9-2b3b-44bc-b8ef-9e45776934b7.pdf",
            "news_date": "2025-10-07 21:27:37"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cf2435c-c15b-411d-b14d-b6449984afce.pdf",
            "news_date": "2025-10-03 21:00:06"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56a6bfa9-dcb8-41bb-aba3-c0e86128d099.pdf",
            "news_date": "2025-09-26 21:40:30"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "Update on Capacity Addition by the Company and at the Subsidiary.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ef6c71e-ac97-487e-a8b9-e1ba3b1d3398.pdf",
            "news_date": "2025-09-26 20:08:27"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=518faae4-f517-4448-baad-f5bdfee6dcd6.pdf",
            "news_date": "2025-09-16 20:12:43"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General",
            "descriptor": "General",
            "caption": "Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Yash Sunil Chari",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33F64135_29AA_4209_915F_C67CD73F9011_125420.pdf",
            "news_date": "2025-09-02 12:54:29"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General",
            "descriptor": "General",
            "caption": "Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jyotishna Sunil Chari",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6DF21CA5_DEEA_49B6_910E_C17D80CCE89D_111738.pdf",
            "news_date": "2025-09-02 11:17:46"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sunil Srinivasan Chari",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B29122D0_DDCF_4BA3_9385_048D197905A4_105243.pdf",
            "news_date": "2025-09-02 10:52:48"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General",
            "descriptor": "General",
            "caption": "Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Chari Family Trust",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=BA721AD0_ABDE_41B8_9677_9AA60950A017_105110.pdf",
            "news_date": "2025-09-02 10:51:15"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Yash Sunil Chari",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F43E2C1B_B156_4451_97AB_0650413FD5F2_104817.pdf",
            "news_date": "2025-09-02 10:48:22"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09f45ff1-56d9-4e22-91a7-08db4f762f68.pdf",
            "news_date": "2025-08-29 17:20:48"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011",
            "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Yash Sunil Chari & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C8F79A11_879F_46AE_BA97_99D6AF940347_115443.pdf",
            "news_date": "2025-08-21 11:54:50"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 .",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bcb6467-19b5-4873-89ea-8259e1e825ef.pdf",
            "news_date": "2025-08-20 23:09:18"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Investor Call.",
            "news_body": "Intimation of non-participation in the investors and analysts meet scheduled on Wednesday August 20 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67bd79a5-a7f4-401a-9f6d-20af1eb8e811.pdf",
            "news_date": "2025-08-20 17:51:27"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=028713ba-6b13-4988-9817-f58bddddd5cf.pdf",
            "news_date": "2025-08-18 18:58:19"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f389eeee-4e0a-451f-a23d-ff859ecdf471.pdf",
            "news_date": "2025-08-11 15:32:11"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q1 FY 26 for the Earnings Conference Call held on July 21 2025.",
            "news_id": "206323e7-716e-4bef-8f97-b14a8dcbf928",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f331ad5b-c905-4ace-a715-baa359eaf89e.pdf",
            "news_date": "2025-07-25 15:36:28",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q1 FY 26 for the Earnings Conference Call held on July 21 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f331ad5b-c905-4ace-a715-baa359eaf89e.pdf",
            "news_date": "2025-07-25 15:36:28"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q1 FY 26.",
            "news_id": "fef131fa-c165-4274-900b-c8ba62e1b203",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc4e76f5-59ee-4555-8dd3-5b2cbdd55b79.pdf",
            "news_date": "2025-07-21 18:57:11",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q1 FY 26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc4e76f5-59ee-4555-8dd3-5b2cbdd55b79.pdf",
            "news_date": "2025-07-21 18:57:11"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding press release dated July 19 2025 titled \"Rossari Biotech  announces Q1 FY 26 results\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a94353af-52db-42e4-92fb-60daa6b45838.pdf",
            "news_date": "2025-07-20 15:43:40"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 FY 26- Earnings Presentation.",
            "news_id": "ce90ebee-0deb-4387-bb97-2405b0e7be6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90423203-077e-4f63-a104-2b207631ed5b.pdf",
            "news_date": "2025-07-20 15:32:31",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 FY 26- Earnings Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90423203-077e-4f63-a104-2b207631ed5b.pdf",
            "news_date": "2025-07-20 15:32:31"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of extract of Consolidated Unaudited Financial Results for the Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e45fc8b3-1b7f-4060-be20-0e2049cf5b42.pdf",
            "news_date": "2025-07-20 13:23:51"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation of allotment of 375 Equity Shares under Rossari Employee Stock Option Plan-2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b385a5d-0aa6-4839-b029-b20b4cf1b49b.pdf",
            "news_date": "2025-07-19 20:38:52"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2025.",
            "news_id": "90ab6f8b-9892-467f-a9b4-d58e43eb77b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92cddd9-9e67-4ead-aa2d-57387d8e9e77.pdf",
            "news_date": "2025-07-19 20:31:48",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92cddd9-9e67-4ead-aa2d-57387d8e9e77.pdf",
            "news_date": "2025-07-19 20:31:48"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On July 19 2025.",
            "news_body": "Outcome of Board Meeting held on July 19 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2af2ee97-bce7-4680-855a-e12b1d076053.pdf",
            "news_date": "2025-07-19 19:34:51"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earning Conference Call for investor and analyst on Monday July 21 2025 at 04:00 P.M. (IST).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73ab0687-40df-4ca6-a34f-5b02b85db971.pdf",
            "news_date": "2025-07-14 20:01:29"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025",
            "news_body": "Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65311a7a-1145-42ad-966f-79b86b7abedd.pdf",
            "news_date": "2025-07-11 20:19:17"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f070832-26ad-4812-b690-93bdaa84e4d4.pdf",
            "news_date": "2025-07-04 17:21:02"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Scrutinizers report for the 16th Annual General Meeting of the Members of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b61c5275-07dd-4381-b6a9-a4f506706ec5.pdf",
            "news_date": "2025-07-01 01:08:21"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome of 16th Annual General Meeting of the Members of the Company along with Proceedings Voting Results and Scrutinizers report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f433baef-e6e9-43b0-98d9-e31f0de21ad9.pdf",
            "news_date": "2025-07-01 01:00:34"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=150f1c03-1a34-4987-838d-e9390fc6c22e.pdf",
            "news_date": "2025-06-26 20:56:45"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Notice of 16th Annual General Meeting of the Company and details relating to E-voting facility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2256246e-555f-48de-9a0f-885089c03a01.pdf",
            "news_date": "2025-06-07 16:15:03"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 -Letters To Non-Email Shareholders",
            "news_body": "Intimation regarding dispatch of letters to non-email shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2a23da3-2ae9-4815-8721-a11e20347939.pdf",
            "news_date": "2025-06-06 23:03:50"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c79a2e57-aac2-48ea-9405-063f0528517e.pdf",
            "news_date": "2025-06-06 22:11:46"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 16Th Annual General Meeting Of The Company",
            "news_body": "Intimation of 16th Annual General Meeting (\"AGM\") of the Company to be held on Monday June 30 2025 at 04:30 P.M. (IST) through Video Conferencing/Other Audio Visual Means (\"VC/OAVM\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58af0e49-af0a-42e7-922e-b6a391052a85.pdf",
            "news_date": "2025-06-06 21:56:30"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88c4592b-31e1-430a-9427-651f06a4c811.pdf",
            "news_date": "2025-06-06 21:33:20"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Notice of information regarding  the 16th Annual General Meeting of the Company scheduled to be held on Monday June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24e722ae-5437-4435-9d92-971c993a26dd.pdf",
            "news_date": "2025-05-30 19:33:32"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Intimation Of 16Th Annual General Meeting Of The Company.",
            "news_body": "The Annual General Meeting of the Company is scheduled to be held on Monday June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b4ea7fe-79fa-4601-a6ca-c171144396f2.pdf",
            "news_date": "2025-05-28 21:16:41"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date.",
            "news_body": "Rossari Biotech Limited informed the Exchange that Record date for the purpose of Final Dividend and for E-voting is Friday June 20 2025 and Monday June 23 2025 respectively.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4909c07-e4b4-456c-ac2e-3cab2b0c14fd.pdf",
            "news_date": "2025-05-28 21:09:51"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3aa0484f-cfdd-4cc2-a276-f283b11d9d25.pdf",
            "news_date": "2025-05-28 20:32:09"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Investor Call.",
            "news_body": "Intimation of cancellation of Investor Call dated Thursday May 22 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc3ba8fa-e33b-4687-8cb0-ed2faeee339b.pdf",
            "news_date": "2025-05-16 20:29:21"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ada756d5-3aff-4055-9c15-de4bdadf6899.pdf",
            "news_date": "2025-05-14 19:45:48"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for UTI Mutual Fund",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85D3BD5A_2973_4841_A350_976BD859F311_170230.pdf",
            "news_date": "2025-05-07 17:02:46"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding Resignation of Mr. Sunil V as Chief Human Resource Officer and Head - Corporate Communication of the Company with effect from May 09 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c2140bc-ee61-48df-9982-1a112fbf5dd3.pdf",
            "news_date": "2025-05-05 20:24:14"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q4 FY 25 for the Earnings Conference Call held on April 28 2025.",
            "news_id": "1500803f-b98d-45cb-9817-22664d41acd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5b0ff25-3178-4b5a-b023-80d4aa6e7e14.pdf",
            "news_date": "2025-05-05 20:00:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q4 FY 25 for the Earnings Conference Call held on April 28 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5b0ff25-3178-4b5a-b023-80d4aa6e7e14.pdf",
            "news_date": "2025-05-05 20:00:24"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q4 FY25.\r\n",
            "news_id": "b0e77462-3b0b-4286-b571-4367b047703e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78a577eb-6caa-4141-b815-f4fbd32d0dfc.pdf",
            "news_date": "2025-04-28 20:32:23",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q4 FY25.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78a577eb-6caa-4141-b815-f4fbd32d0dfc.pdf",
            "news_date": "2025-04-28 20:32:23"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of extracts of Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cab4613-ca6a-4665-b61b-cbec4e40b7d7.pdf",
            "news_date": "2025-04-26 23:38:31"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding press release dated April 25 2025 titled \"Rossari Biotech announces Q4 & FY25 results\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd078f38-6284-4b80-be86-778b898c6f67.pdf",
            "news_date": "2025-04-26 23:31:33"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 FY 25 - Earnings Presentation.",
            "news_id": "522afbcc-f646-4400-80a6-23f1eba0c10f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=117b9536-8cbe-46a8-98fc-1974e72d1db7.pdf",
            "news_date": "2025-04-26 23:24:03",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 FY 25 - Earnings Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=117b9536-8cbe-46a8-98fc-1974e72d1db7.pdf",
            "news_date": "2025-04-26 23:24:03"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ",
            "news_body": "Intimation of approval of capacity addition.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5872209c-2030-48e3-b1b0-e430af5606b0.pdf",
            "news_date": "2025-04-25 23:22:58"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Appointment of M/s. Shah Patel & Associates Practicing Company Secretaries as Secretarial Auditor of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=263c765b-57d0-45aa-b1d3-aae65677c752.pdf",
            "news_date": "2025-04-25 23:15:51"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan- 2019",
            "news_body": "Intimation of grant of 834250 options under Rossari Employee Stock Option Plan -2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f9c8b79-fbd0-4246-8d4e-805ed3b3cb94.pdf",
            "news_date": "2025-04-25 22:53:07"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation of allotment 2825 Equity shares under Rossari Employee Stock Option Plan -2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604a1f5b-fa85-403a-9db2-ca3604c1c8d3.pdf",
            "news_date": "2025-04-25 22:40:13"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025.",
            "news_body": "Audited Financial Results(Standalone and Consolidated) for the quarter and financial year ended March 31 2025.",
            "news_id": "b59f2302-8e89-46b7-8a27-6b84ca7888c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8261f937-8244-470c-8f32-4276fdada835.pdf",
            "news_date": "2025-04-25 21:11:48",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025.",
            "news_body": "Audited Financial Results(Standalone and Consolidated) for the quarter and financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8261f937-8244-470c-8f32-4276fdada835.pdf",
            "news_date": "2025-04-25 21:11:48"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Board has recommended final dividend of 25% i.e Re. 0.50/- per share on Equity shares of the face value of Rs. 2/- each for the Financial Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22a4bd70-0c4e-44fb-ab91-51590c99d413.pdf",
            "news_date": "2025-04-25 20:56:21"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On April 25 2025.",
            "news_body": "Outcome of Board Meeting held on April 25 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b87a912f-8eb6-4797-bd05-2d74e7a24cf2.pdf",
            "news_date": "2025-04-25 20:38:36"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20d1cd1d-3d5d-46df-b254-ff38ece9a676.pdf",
            "news_date": "2025-04-25 00:19:31"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earnings Conference call for investors and analysts on Monday April 28 2025 at 05:00 PM IST.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ef78681-a490-4698-985a-fc88e411d130.pdf",
            "news_date": "2025-04-22 22:31:52"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change Of Communications Details Of Registrar And Share Transfer Agent",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding intimation of change of communications details of MUFG Intime  India Private Limited (Registrar and Share Transfer Agent) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2df01893-52fd-470a-af1a-1614cfa593ea.pdf",
            "news_date": "2025-04-18 20:12:59"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025 And Recommendation Of Final Dividend If Any.",
            "news_body": "Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 inter alia to consider and approve 1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31 2025.\r\n\r\n2. recommend payment of Final Dividend if any for the Financial Year ended March 31 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bc4ba64-5d89-49f3-aef8-5ab15aacf939.pdf",
            "news_date": "2025-04-17 22:38:56"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9ded705-53c8-463c-a643-1f10c1879ead.pdf",
            "news_date": "2025-04-03 19:09:27"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84df89a3-60c6-46f8-94fc-7f5902a2906b.pdf",
            "news_date": "2025-03-26 20:48:29"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a323cb9d-1750-44d7-8207-568aaff38209.pdf",
            "news_date": "2025-02-20 11:26:33"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "Intimation of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fcda521-523f-4fb3-a841-b803773a63e9.pdf",
            "news_date": "2025-02-06 15:35:35"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Analyst/Institutional Investor Meet/Con. Call/Updates.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46a80299-9e43-49d6-80c9-39658dc6b88f.pdf",
            "news_date": "2025-02-03 20:37:50"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f91b3215-82fa-4720-a7a4-a90efef5d6e9.pdf",
            "news_date": "2025-01-31 19:41:20"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Conference call for Q3 FY 25 held on January 23 2025.",
            "news_id": "8805bd7a-d6a2-43d3-849b-15d7edc3552f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ac5ec2-5424-4c13-8fcd-ef9ccc9392b2.pdf",
            "news_date": "2025-01-28 19:45:49",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Conference call for Q3 FY 25 held on January 23 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ac5ec2-5424-4c13-8fcd-ef9ccc9392b2.pdf",
            "news_date": "2025-01-28 19:45:49"
        },
        {
            "co_code": 72633,
            "bse_code": 543213,
            "isin": "INE02A801020",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financial) for the quarter and nine months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce72df16-3fbe-4755-a5bc-866d30dec402.pdf",
            "news_date": "2025-01-28 18:28:07"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q3 FY 25 - Earnings Presentation.",
            "news_id": "826a6564-d383-487b-a6bc-9054a51ffb0f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=484acb2b-b9ba-41a9-afbf-dcc6a9aef183.pdf",
            "news_date": "2025-01-22 20:20:46",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024.",
            "news_id": "a7cdeb40-39b5-4aa6-80af-89effd26bd70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7fb0245-6b96-4f35-b63a-1133007b5298.pdf",
            "news_date": "2025-01-21 19:09:15",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for Q2 FY25",
            "news_id": "fdcb8448-d662-4516-9480-e45599c34aab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d96ddf06-d3a0-4cdf-ae1c-985798225f79.pdf",
            "news_date": "2024-10-25 22:39:41",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recordings of Earnings Conference Call Q2 FY25",
            "news_id": "f7f94f63-6f69-436e-b0c7-0fc514df9bf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da4888dd-d239-486b-8364-e421a281edde.pdf",
            "news_date": "2024-10-21 20:02:03",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation Q2 H1 FY 25 (Readable format)",
            "news_id": "bce9d255-280a-46a1-b58e-aec8a8125fe0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fae57ef-62dd-4c3a-a2ce-e48b30d8f5e9.pdf",
            "news_date": "2024-10-20 15:32:29",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for Q2 H1 FY25",
            "news_id": "10164ae8-422e-4c84-bd1a-6b8a6944cb4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5e3d388-a15c-498b-9427-5418b7252be6.pdf",
            "news_date": "2024-10-20 12:55:15",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024 - (Readable)",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2024 - (Readable)",
            "news_id": "fd16f9ef-010e-48ed-8a05-061b8555fea5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0ed1646-8737-4369-b77b-7d6fb3039f9c.pdf",
            "news_date": "2024-10-19 16:40:07",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024.",
            "news_body": "The Board of Directors of have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September, 30, 2024.",
            "news_id": "fd5ab9c2-f00d-4b2f-a2cc-adf768b781e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa08db5c-c93f-432d-84c7-dbfe8b2bcc4f.pdf",
            "news_date": "2024-10-19 15:24:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q1 FY 25 for the Earnings Conference Call held on July 22, 2024.",
            "news_id": "5ea48e88-bc0f-48e6-b557-71de87200cde",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f5e4e94-fbca-40f6-84f4-8dd463e78e6b.pdf",
            "news_date": "2024-07-26 19:29:50",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q1 FY25",
            "news_id": "daa9d441-5351-4b8b-987b-5a304117ed60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc0a5538-9729-43ba-80b9-69c276c5cb32.pdf",
            "news_date": "2024-07-22 23:25:52",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 FY 25 - Earnings Presentation.",
            "news_id": "4c6cf574-115e-4a9a-8bd8-023c9f595a24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e850e40b-0c79-405b-afed-9ac0701cc3a7.pdf",
            "news_date": "2024-07-21 13:28:59",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Outcome Of Board Meeting Held On July 20, 2024",
            "news_body": "The Board of Directors have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024.",
            "news_id": "4ebcb2c5-6d21-4534-9044-831c5492a1d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25e9d5da-3199-40e9-83de-1a1812b72c78.pdf",
            "news_date": "2024-07-20 19:33:52",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q4 FY 24 for the Earnings Conference Call held on April 30, 2024",
            "news_id": "e10da42b-a750-4cb8-8eb1-deb057fe47b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09d45a5b-ddda-4f0c-8d04-692fc1d63370.pdf",
            "news_date": "2024-05-07 23:21:33",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q4 FY 24",
            "news_id": "e3764e53-f451-4f51-994d-d416dd9bad2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45d8337c-62e5-4921-ac92-566d977a2a6e.pdf",
            "news_date": "2024-04-30 18:43:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 FY 24 - Earnings Presentation.",
            "news_id": "8e06aa23-3c5a-4241-bf92-08da394e19b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f52e0c8-943a-49e6-8d98-2ff9a56c2146.pdf",
            "news_date": "2024-04-30 13:09:58",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Statements (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2024.",
            "news_body": "Audited Financial Results and Statements (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024.",
            "news_id": "8b86b313-a10e-4e23-b525-a8d87a99d4af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68beeebe-0dd5-4e5c-94bf-a7ed41c5ba99.pdf",
            "news_date": "2024-04-29 19:26:17",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "The Board of Directors have inter alia approved the Audited Financial Results and Statements (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024 and Final Dividend for the Financial Year 2023-24.",
            "news_id": "4c5fd862-18e2-4325-aa7b-4c142ab36933",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65cebd3c-c57b-409d-b2dc-1dbc67d5e04e.pdf",
            "news_date": "2024-04-29 19:19:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q3 FY 24 for the Earnings Conference Call held on 23 January, 2024.",
            "news_id": "b12f0eda-d840-4c79-b4ae-1343d3e04887",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20faac65-efdc-480a-a614-72cac44e65e7.pdf",
            "news_date": "2024-01-30 15:47:05",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference Call for Q3 FY24",
            "news_id": "6fce045f-3cf4-4b03-ba29-4a41da292564",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cdb2724-8f6f-4a52-b1b7-1931bae81530.pdf",
            "news_date": "2024-01-23 22:51:21",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q3 FY24- Earnings Presentation.",
            "news_id": "89ba3a15-4b05-48a6-8bd6-664abf11c564",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47de23ac-e506-405c-9d14-3d15570bdec2.pdf",
            "news_date": "2024-01-21 16:23:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Rossari Biotech Limited Has Informed The Exchange Regarding Board Meeting Held On January 20, 2024.",
            "news_body": "The Board of Directors of the Company at their meeting held on January 20, 2024, have interalia approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (Revised)",
            "news_id": "f5780233-046c-4c1d-a2f5-ca5e25ef2a81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=716a3087-0f56-4af6-b435-6ca0ddcbd13a.pdf",
            "news_date": "2024-01-20 18:20:12",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of transcript of the Q2 and H1 FY24 Earnings Conference Call held on October 23, 2023",
            "news_id": "51db1667-2d12-4158-9642-946bbf9070b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=854680f7-1791-455a-9a1e-670b504660ef.pdf",
            "news_date": "2023-10-27 17:47:25",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference Call for Q2 FY24",
            "news_id": "479f3f22-03f5-4745-ba23-840ac7519ee2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6236f35e-7e41-4d0e-97bd-253415462306.pdf",
            "news_date": "2023-10-25 11:29:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q2 FY24- Earning Presentation.",
            "news_id": "f6440050-c6d2-45a9-89a3-7c045be6808d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1231a7d-f2ec-437d-81ca-08c7aa960eb3.pdf",
            "news_date": "2023-10-22 13:32:32",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting-21.10.2023",
            "news_body": "The Board of Directors have interalia approved Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September, 2023 and other matters.",
            "news_id": "dd652c74-e1bb-4167-a418-ab2804aaaf1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0248d754-5087-4116-a7bc-f7f9b0be4951.pdf",
            "news_date": "2023-10-21 15:02:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For Quarter And Half Year Ended September 30, 2023",
            "news_body": "The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter and half year ended September 30, 2023 of the Financial Year 2023-24 and other matters.",
            "news_id": "ce4a2b76-aa12-405b-a456-2a2a418d31ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07771473-c87d-44d0-b15c-fd181ae3f938.pdf",
            "news_date": "2023-10-21 14:58:54",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q1 FY24 Earnings Conference Call held on July 31, 2023",
            "news_id": "36bdef92-3ae7-4a69-b510-7e1abee1d47b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8e48e6-7f20-4efd-a302-31c783655efd.pdf",
            "news_date": "2023-08-04 11:48:03",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q1 FY24",
            "news_id": "89162acf-4eae-4345-8e71-3b3026171221",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=041a1343-2b35-4b24-8d79-1ec9d4a4e04d.pdf",
            "news_date": "2023-07-31 19:29:39",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 FY24 Earnings Presentation",
            "news_id": "5a39a20c-4b5c-4756-9d81-f269e9f430a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dda4eec-215f-472a-8845-d1f8062e5d6d.pdf",
            "news_date": "2023-07-29 22:07:13",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, July 29, 2023",
            "news_body": "The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2023 of the Financial Year 2023-24 and other matters.",
            "news_id": "93235012-1b99-4165-98f1-f7d9ed1844f0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4b36c29-e7e9-4958-bccb-0fae218777c5.pdf",
            "news_date": "2023-07-29 14:40:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q4 FY23 Earnings Conference Call held on May 02, 2023",
            "news_id": "d39ea824-74d6-4611-bfe5-7f4993637c0b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a42320d0-b89f-476a-9b6f-1c862c0a7a71.pdf",
            "news_date": "2023-05-08 19:24:04",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q4 FY23",
            "news_id": "ae9b5f51-5e15-4818-8ba1-0eba4994face",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=268e965f-0df6-467f-a9ff-4948ff025c16.pdf",
            "news_date": "2023-05-02 20:45:21",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 & FY23 Earnings Presentation.",
            "news_id": "a99f909b-4efa-4316-a4f1-da801bfca3c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=798fe4b6-ceee-4fdd-9ce6-53f2d4152e46.pdf",
            "news_date": "2023-04-30 16:10:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Saturday, April 29, 2023",
            "news_body": "The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2023 of the Financial Year 2022-23 and other matters.",
            "news_id": "039cb02a-3534-46dd-8558-2b0397086194",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2a8804f-eafc-4ac4-a1ab-469104bef5d0.pdf",
            "news_date": "2023-04-29 16:52:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q3 FY23 Earnings Conference Call held on February 06, 2023",
            "news_id": "29e11aa2-12df-442d-8625-e5913f06bd81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea636412-66b2-4ef6-95b2-9294678fca1a.pdf",
            "news_date": "2023-02-10 17:57:39",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q3 FY23",
            "news_id": "0fdd1a4d-83b0-4131-8695-3b2a6b8ffa15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=535ad374-9e3c-4af0-8e1c-d765d60b07b7.pdf",
            "news_date": "2023-02-06 18:55:35",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of revised Q3 & 9M FY23 Earnings Presentation",
            "news_id": "36e31f68-56a6-49fc-9835-c529161c5f08",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a312ebfa-a6d0-4944-a660-677895d281e3.pdf",
            "news_date": "2023-02-05 16:04:59",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY23 Earnings Presentation",
            "news_id": "8bfe4e03-bd01-4793-b715-5396b553af38",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=568fb915-f0ff-4c41-8714-ad58f770acd5.pdf",
            "news_date": "2023-02-05 11:02:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On February 04, 2023",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 for the Financial Year 2022-23 and other matters.",
            "news_id": "b5f680b8-64fb-403a-b638-23e5ce7f280c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c54462d-19bc-440c-91a9-ceb0cc4450a7.pdf",
            "news_date": "2023-02-04 15:53:54",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 04, 2023",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 for the Financial Year 2022-23 and other matters.",
            "news_id": "e73e487e-a8f1-4ea2-b901-19feff6e535b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a564f902-9ef9-43f4-b130-b782cf14d59c.pdf",
            "news_date": "2023-02-04 14:55:38",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions On Consolidated Basis For The Half Year Ended September 30, 2022",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the disclosure of Related Party Transactions on a consolidated basis, in the prescribed format, for the half year ended September 30, 2022.",
            "news_id": "1c5bbe66-a4be-40cc-9fe3-6da413771bcf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=617806ce-d95f-4435-bd53-73111b43c83b.pdf",
            "news_date": "2022-11-18 19:46:33",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q2 & FY23 Earnings Conference Call held on November 07, 2022",
            "news_id": "56939c52-ee40-4814-87b5-98ad12b6719e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e806c2a7-b5b2-4924-a987-0937ef544d48.pdf",
            "news_date": "2022-11-11 20:44:09",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q2 & FY23",
            "news_id": "64292af2-6dd0-40aa-bb12-f690e37ccf1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=473d1917-2c10-4b99-85f9-d762a5b0920b.pdf",
            "news_date": "2022-11-07 14:40:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 & FY23 Earnings Presentation",
            "news_id": "dbc5e3b4-cd04-4d34-9dfb-11bb12f42556",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a47cc0db-a4d7-40b1-a0fd-f5a725476d31.pdf",
            "news_date": "2022-11-05 23:48:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 05, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022 for the Financial Year 2022-23 and other matters.",
            "news_id": "d265d1fa-80c6-468c-a649-44c851a36bcc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cda9f5db-1e68-4f82-a84f-50e5e6eddffe.pdf",
            "news_date": "2022-11-05 14:35:36",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q1 & FY23 Earnings Conference Call held on August 09, 2022",
            "news_id": "2d8f9157-8ea8-4a82-8713-757bca452ea4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10ad1c43-c4b3-4ad7-a18d-1282c08834c1.pdf",
            "news_date": "2022-08-16 17:53:04",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1 & FY23 Earnings Presentation",
            "news_id": "38221b3c-e3b7-4614-827d-3625f7d03833",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=234097bf-8a15-4d6e-a7bd-9b2dbdbd30fa.pdf",
            "news_date": "2022-08-07 12:07:46",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome Of Meeting Held On August 06, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022 of the Financial Year 2022-23.",
            "news_id": "b9f078cc-6711-4a31-b6a2-675af040dad8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae8d1705-edac-45dc-a985-a11de3375d8e.pdf",
            "news_date": "2022-08-06 16:06:00",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Board Meeting Outcome Of Meeting Held On August 06, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022 of the Financial Year 2022-23.",
            "news_id": "de91defd-766b-4c32-aa0d-f423206f594e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fad60919-55ab-4076-b6cd-2da04133c18c.pdf",
            "news_date": "2022-08-06 16:04:00",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions On Consolidated Basis For The Half Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the disclosure of Related Party Transactions on a consolidated basis, in the prescribed format, for the half year ended March 31, 2022.",
            "news_id": "579798e5-2f1d-468e-831a-fb300d579b7c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a319d607-bb41-4cdf-92cb-fbc307b8eb85.pdf",
            "news_date": "2022-06-02 20:37:34",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q4 & FY22 Earnings Conference Call held on May 23, 2022",
            "news_id": "6e775d18-0ef3-49e3-a16a-cd9eaea54cdf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce6fb66a-7168-4e6e-b36f-2cb7760a0866.pdf",
            "news_date": "2022-05-27 12:46:28",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of revised Q4 & FY22 Earnings Presentation",
            "news_id": "5b969b0c-bd38-4611-9933-3268636e7cfd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f176d4f0-717a-4a78-82e7-cab039a431a5.pdf",
            "news_date": "2022-05-24 19:37:29",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q4 & FY22",
            "news_id": "800e02bf-ff62-4797-a4c9-6bbe098569cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a335d13-c163-4969-8f5f-756f675ca5ee.pdf",
            "news_date": "2022-05-23 21:15:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 & FY22 Earnings Presentation",
            "news_id": "f5947064-74f5-48da-abb4-880fc32aceae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbd6418e-1741-4f32-b1a0-165841c70f85.pdf",
            "news_date": "2022-05-20 20:01:14",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Thursday, May 19, 2022",
            "news_body": "The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022 of the Financial Year 2021-22 and other matters.",
            "news_id": "95ef731b-6925-4bfc-9fb2-40c7751b0281",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=460049ca-33e8-4eed-9428-1854938453be.pdf",
            "news_date": "2022-05-19 23:26:56",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q3 & 9M FY22 Earnings Conference Call held on February 15, 2022",
            "news_id": "1561d1dc-7ad2-4752-a9cf-6e4838c5f8c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f75b4b6-95d4-412e-88cb-b274c840827e.pdf",
            "news_date": "2022-02-28 18:54:10",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY22 Earnings Presentation",
            "news_id": "b5bdf1f7-efab-4ea5-8800-cdd18b479b0a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=089d488c-52f4-4c49-8d8c-e7fc654d68bb.pdf",
            "news_date": "2022-02-14 22:43:44",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 14, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021 of the Financial Year 2021-22.",
            "news_id": "daa8445b-f327-4396-b9b9-ab0f6c75621b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=659bdc7b-9f2d-4e22-93ac-bf9cecc01bfb.pdf",
            "news_date": "2022-02-14 17:19:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q2 FY2022 Earnings Conference Call held on November 01, 2021<BR>",
            "news_id": "28b742c1-3607-47be-90b4-f49e91615218",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a99d01c-a9ed-4cd3-87e8-4d4ead7fbd0d.pdf",
            "news_date": "2021-11-12 16:26:49",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 FY22 Earnings Presentation",
            "news_id": "ffdbc24e-0c92-4eb1-b3ad-613155a21516",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c875304-d94c-4c41-8def-d0f877edbf0e.pdf",
            "news_date": "2021-10-30 22:44:36",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On October 30, 2021",
            "news_body": "The Board has Inter alia approved the following: <BR> <BR> 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2021. <BR>  <BR> 2. Appointment of Mr. Ketan Sablok as Group Chief Financial Officer.<BR> <BR> 3. Appointment of Mr. Debashish Vanikar as Chief Executive Officer - New Businesses.<BR> <BR> 4. Grant of Options under Rossari Employee Stock Option an - 2019.<BR>",
            "news_id": "f838e4cc-3e0c-4a74-8a4f-c5245cb51738",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24cfd362-ba7b-419d-bbd9-aad3ef9ab768.pdf",
            "news_date": "2021-10-30 16:24:18",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q1 FY2022 Earnings Conference Call held on August 02, 2021",
            "news_id": "84a9b4f0-f05d-42e1-8195-4c7226701666",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44b7c8da-eb19-4649-9477-04670f0fe397.pdf",
            "news_date": "2021-08-13 21:14:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Analysts/Institutional Investor Meet/Con. Call Update",
            "news_id": "3c8be8a9-a58d-4a17-aaf3-69ffbf605498",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67831d1f-06d2-480e-8399-99a71ba495de.pdf",
            "news_date": "2021-08-13 20:25:30",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 & FY22 Earnings Presentation<BR>",
            "news_id": "243764b8-7659-4860-9536-7465688f560d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10713117-e65c-4ae1-b49a-aac498c65eb1.pdf",
            "news_date": "2021-07-31 10:05:29",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On July 30, 2021",
            "news_body": "Inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2021 of the Financial Year 2021-22.",
            "news_id": "fa45543e-d944-46d0-a247-a4c21faa3115",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91bd0eae-91a7-47eb-b7eb-434545041d12.pdf",
            "news_date": "2021-07-30 17:32:13",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Conference Call held on July 19, 2021",
            "news_id": "8618f1ee-5db6-4747-ae83-f74635435ab9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d3fd779-3c3c-4dea-9517-b307754dcefb.pdf",
            "news_date": "2021-07-26 18:09:26",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Conference Call held on June 02, 2021",
            "news_id": "473ddc7c-79a2-4beb-88ba-7cc3b796ec6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b01c3b2-d800-460e-887a-7d348ba1a7bf.pdf",
            "news_date": "2021-06-14 14:52:51",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q4 FY2021 Earnings Conference Call held on May 17, 2021",
            "news_id": "f6675a72-15bf-4a47-9e7b-a0b02a7a5c52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02adf6b4-9582-40c6-ae14-a977ee76b395.pdf",
            "news_date": "2021-05-26 16:58:02",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 & FY21 Earnings Presentation",
            "news_id": "0ca1f774-a8ac-48a3-b424-011d659e582e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=827b9e27-6d00-4d20-b269-476b7599a617.pdf",
            "news_date": "2021-05-15 09:08:22",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Friday, May 14, 2021",
            "news_body": "The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2021 of the financial year 2020-21 and other matters.",
            "news_id": "71c6298b-ca3e-4a9c-8403-819a8eb2f9c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6462f0da-e8e1-4370-a023-5a4af527a9c8.pdf",
            "news_date": "2021-05-14 18:45:57",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}